Apixaban for reduction in stroke and other ThromboemboLic events in atrial fibrillation (ARISTOTLE) trial: design and rationale.
type: Dataset
description: International audience
issued: 2026-05-07T10:52:52.174629
language: en
modified: 2026-05-07T10:52:52.174634
contact point: Organization
  fn: CCSD
keyword: infoeu-reposemanticsarticle
keyword: journal-articles
keyword: mesh-adolescent
keyword: mesh-adult
keyword: mesh-aged
keyword: mesh-anticoagulants
keyword: mesh-atrial-fibrillation
keyword: mesh-factor-xa
keyword: mesh-fibrinolytic-agents
keyword: mesh-follow-up-studies
keyword: mesh-hemorrhage
keyword: mesh-humans
keyword: mesh-international-normalized-ratio
keyword: mesh-middle-aged
keyword: mesh-pyrazoles
keyword: mesh-pyridones
keyword: mesh-research-design
keyword: mesh-stroke
keyword: mesh-thromboembolism
keyword: mesh-treatment-outcome
keyword: mesh-warfarin
keyword: mesh-young-adult
keyword: sdvlife-sciences-q-bio
landing page: 0002-8703

Apixaban for reduction in stroke and other ThromboemboLic events in atrial fibrillation (ARISTOTLE) trial: design and rationale.
type: Distribution
format: HTML
issued: 2026-05-07T10:52:52.188906
modified: 2026-05-07T10:52:52.151033
access URL: https://hal.univ-brest.fr/hal-00930087

test_moissonnage_selune
type: Agent